Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.
about
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 yearsADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsUnderstanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular functionOmega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysisAtomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescentsParent training interventions for attention deficit hyperactivity disorderA Review of Pharmacological Management of Attention-Deficit/Hyperactivity DisorderCreatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-AnalysisA review of atomoxetine effects in young people with developmental disabilitiesNutritional supplements for the treatment of ADHDPractitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescentsEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentADHD in children and adolescents.Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trialsPost hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trialA systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.The quality of life of children with attention deficit/hyperactivity disorder: a systematic review.Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.Drug therapy of attention deficit hyperactivity disorder: current trends.Advancing services for adult ADHD: the development of the ADHD Star as a framework for multidisciplinary interventions.Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorderComparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysisAttention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review.Multimodal treatment for childhood attention-deficit/hyperactivity disorder.Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.Priority mental health disorders of children and adolescents in primary-care pediatric settings in India 2: diagnosis, pharmacological treatment and referral.Atomoxetine for treating ADHD symptoms in autism: a systematic review.Toward quality care in ADHD: defining the goals of treatment.Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review.Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available meta-analyses.Interventions for executive function deficits in children and adolescents.Developments and challenges in the diagnosis and treatment of ADHD.The relationship between ADHD and obesity: implications for therapy.
P2860
Q22061984-BAAE66E8-654A-444B-91C1-5DBBFCF1DBC4Q22241496-695D1EA5-F620-41A4-8137-8A6B5C0EDC0AQ22252308-CEC8AE2F-BC41-4168-A51E-A1DDBF79C21AQ22252430-FFF1B947-872B-4EF1-9E47-CE82F3996F5FQ24200716-BDEFB6D3-B45D-4FA9-B327-8277595C3603Q24240470-825C8763-B309-457E-B8B4-836F0CCA1963Q26741896-1750362E-A94B-4D6A-8CE5-10DA2CADB4A2Q26795734-18E5A4B0-FCB4-4520-A32B-E6826CDB3F90Q26863679-AA9C6142-379B-43AE-800D-05F3809E0FA5Q28247932-B73AA006-8BB3-4774-A1BC-BE40CACCE87EQ28282770-671B1BBF-8D45-4AA3-87EF-EB349CD33710Q28972478-CDC287AA-C929-4C87-99E0-6334889792E7Q33947402-67136E92-D8C1-4D6B-9EA8-73D41E23AE4DQ34072167-A2257F99-D141-403A-9F35-2857A0E9AFD0Q34447938-E2CB79B6-5A69-4026-8F5E-471FBF836A18Q34449469-F9966BBE-E064-4950-A830-4B0BE6D72112Q34650130-2882ED67-578C-43FD-8A1D-88BBF0ACC38FQ35084047-AAEDAF2D-F870-456C-98BE-99F3002DD058Q35563516-B7D5F3E5-4254-43A8-AD3E-A6C2D7E6C33AQ35964370-B18FBD92-FF09-4C03-84C7-9BCE9F0F1264Q36184806-4063C563-963E-4D1B-B746-E4BC9AEC6B17Q36751226-55001E25-CDB0-4068-8C3D-B8276E4936CFQ36983210-F8F71A77-52EC-4054-9F57-3AE5DA81F9A7Q37187469-7DDFE280-E0BA-40D4-A0CB-BBC496F11501Q37208559-D31B38C5-9DE0-470A-B3BB-6FC387A91C19Q37224562-95B26A60-1D16-43A1-AACE-594294F6FF00Q37301226-8D921F5E-761C-4C88-93A4-D9551D8A1B7DQ37598192-0C357A71-94A1-4A75-A281-BB57003E7EADQ37603815-FE604FD2-F503-4834-A471-995D75C6FCB8Q37618812-172A7E84-6752-4BA9-988F-F8D4523F5C08Q37638740-CA076244-0E64-415B-8749-6C124967D86EQ37834860-6318FB74-1FFC-488D-8E5D-157F277886ACQ37880651-B47469BD-6A74-4C9A-A7F8-18FCF387F543Q38006416-013D814A-D1BE-4626-BBA3-10825966AF07Q38082894-AA71301C-5487-4410-8B46-B58714749C5BQ38112064-B55A9E2B-8510-499E-BC26-4CACB95E52F4Q38112253-6A1612F9-2FD8-45F9-BEA8-8B1B35A66A64Q38121124-BC4902B0-B698-41AF-84B2-2EFD9314D347Q38154181-86F4CF8E-955B-470E-888D-4631DFEA7339Q38202135-B15360C5-9961-4473-B564-9D54CCD02D7E
P2860
Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@en
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@nl
type
label
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@en
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@nl
prefLabel
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@en
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@nl
P2093
P2860
P921
P1433
P1476
Efficacy and safety of atomoxe ...... and meta-regression analysis.
@en
P2093
Emil M L Ng
Jackie Y W Cheng
John S N Ko
Ronald Y L Chen
P2860
P2888
P304
P356
10.1007/S00213-007-0840-X
P577
2007-06-16T00:00:00Z